Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

July 21, 2025

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

News Daily News

Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis

June 27, 2025

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

News Daily News

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

May 15, 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 28, 2025

April 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

April 18, 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

March 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

March 21, 2025

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

CVD Hospitalization in Older Adults Higher in US Than in Denmark

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

January 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

January 24, 2025

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

News Daily News

GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks

January 21, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.